Sign In
Buy CNTA
$39.85
-0.0500 (-0.125%)
At Close: Jun 03, 2026
Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs
12:24pm, Tuesday, 31'st Mar 2026
Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion, marking a significant expansion of the drugmaker's neuroscience portfolio into sleep medicine. Under th
MILWAUKEE, March 31, 2026 /PRNewswire/ -- LLP is investigating Centessa (NASDAQ: CNTA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Li
Dow Eyes Worst Month Since 2022 Despite Last Minute Flourish
11:52am, Tuesday, 31'st Mar 2026
Stocks are higher but all three major indexes are on track for monthly and quarterly losses
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?
11:38am, Tuesday, 31'st Mar 2026
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio
11:37am, Tuesday, 31'st Mar 2026
Eli Lilly and Co $LLY said on Tuesday it will acquire Centessa Pharmaceuticals $CNTA for $38 per share in cash, with a potential contingent value right (CVR) worth up to $9 per share, valuing the deal
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
10:46am, Tuesday, 31'st Mar 2026
Eli Lilly will pay up to $7.8 billion to acquire Centessa Pharmaceuticals. Centessa is developing orexin agonists to treat narcolepsy and excessive drowsiness.
Why Eli Lilly Is Buying Centessa for $7.8 Billion
10:27am, Tuesday, 31'st Mar 2026
Bloomberg Intelligence's Sam Fazeli discusses Eli Lilly's $7.8 billion acquisition of Centessa, marking the company's entry into the sleep disorder drug market. He speaks on "Bloomberg Open Interest.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Centessa Pharmaceuticals plc (NASDAQ: CNTA) to Eli Lilly and Company for $38.00 in cash per shar
Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio
07:26am, Tuesday, 31'st Mar 2026
Eli Lilly and Co (NYSE:LLY) said on Tuesday it will acquire Centessa Pharmaceuticals PLC (NASDAQ:CNTA) for $38 per share in cash, with a potential...
Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion
07:18am, Tuesday, 31'st Mar 2026
Eli Lilly has agreed to buy clinical-stage company Centessa Pharmaceuticals for an initial $6.3 billion in a deal that expands the drugmaker's neuroscience portfolio and capabilities into sleep medici
Eli Lilly to buy Centessa Pharma in $6.3 billion deal
06:53am, Tuesday, 31'st Mar 2026
Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal worth about $6.3 billion to advance treatments for sleep-wake disorde
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
06:45am, Tuesday, 31'st Mar 2026
Centessa's OX2R agonist pipeline includes a potential best-in-class therapeutic with significant promise to meaningfully improve outcomes across a range of sleep-wake disorders Acquisition expands Lil
Karen Anderson Sells 41,076 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock
04:38am, Saturday, 28'th Mar 2026
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report) insider Karen Anderson sold 41,076 shares of the stock in a transaction on Thursday, March 26th. The shares were sold at an
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of “Buy” from Brokerages
02:22am, Monday, 23'rd Mar 2026
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report) has been assigned an average recommendation of "Buy" from the thirteen ratings firms that are covering the company, Marketbe
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells $1,927,250.68 in Stock
04:21am, Monday, 16'th Mar 2026
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report) insider Gregory Weinhoff sold 73,196 shares of the stock in a transaction on Friday, March 13th. The shares were sold at an
